Skip to main content

Disclaimer

Important Notice: THE CLINIC TELEHEALTH offers the services on this website through Leg Up Recovery, which operates the platform and is the party to these terms and conditions, this privacy policy and the related legal documents where they say "we". THE CLINIC TELEHEALTH may receive compensation for referrals made through this website. All medical services are provided by independent licensed healthcare providers affiliated with Leg Up Recovery. THE CLINIC TELEHEALTH does not provide medical services or prescription drugs directly, unless otherwise specified.

The information provided on this website is for general informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. The products and statements discussed on this website—excluding prescription medications when true—have not been evaluated by the U.S. Food and Drug Administration (FDA).

Semaglutide, tirzepatide, and other GLP-1 receptor agonist medications may not be approved by the FDA for all uses discussed. This information is for educational purposes only and is not intended as medical advice. Always consult a licensed healthcare professional before starting any new medication or treatment.

Always consult a qualified healthcare professional before making any changes to your diet, lifestyle, or treatment plan. If you have or suspect a medical condition, consult your healthcare provider.

Prescription medications offered on this site are provided in accordance with applicable laws and under the guidance of licensed medical professionals. Please do not reply to any of our marketing messages or sales phone calls with any personal health information.

Our delivery estimator is just an estimate and is not guaranteed. Not all medicine or services are available in all states. Medical services are referral-based and provided through licensed healthcare professionals. Prescription medications are fulfilled by Leg Up Recovery.

Important Notes:

  • *Compounded semaglutide is not FDA-approved and the FDA does not evaluate compounded products for safety, effectiveness, or quality. Ozempic® and Wegovy® are not compounded. Ozempic® and Wegovy® are both products and registered trademarks or Novo Nordisk A/S. Ozempic® is FDA-approved for type 2 diabetes but may be prescribed off-label for weight loss per a healthcare practitioner's discretion. Wegovy® has been approved by the FDA for diabetes and weight loss.
  • *Compounded tirzepatide is not FDA-approved and the FDA does not evaluate compounded products for safety, efficacy or quality. Mounjaro® is FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss per a healthcare practitioner's discretion. Mounjaro® is a product and registered trademark of Eli Lily and Company.

Last updated: December 29, 2025

All content Copyright © 2026, THE CLINIC TELEHEALTH.